PIP-AMITRIPTYLINE amitriptyline hydrochloride 50mg tablet blister pack

País: Austràlia

Idioma: anglès

Font: Department of Health (Therapeutic Goods Administration)

ingredients actius:

amitriptyline hydrochloride, Quantity: 50 mg

Disponible des:

Ipca Pharma (Australia) Pty Ltd

Designació comuna internacional (DCI):

amitriptyline hydrochloride

formulario farmacéutico:

Tablet

Composición:

Excipient Ingredients: purified talc; hypromellose; macrogol 6000; sunset yellow FCF aluminium lake; microcrystalline cellulose; lactose monohydrate; titanium dioxide; crospovidone; maize starch; magnesium stearate; colloidal anhydrous silica; indigo carmine aluminium lake

Vía de administración:

Oral

Unidades en paquete:

20, 50 and 100

tipo de receta:

(S4) Prescription Only Medicine

indicaciones terapéuticas:

For the treatment of major depression. Amitriptyline 50 mg tablets are indicated only for the maintenance treatment of major depression ,Nocturnal enuresis where organic pathology has been excluded.

Resumen del producto:

Visual Identification: Brown colour, circular, biconvex, film coated tablets with 'IA' over '50' debossed on one side and plain on the other side.; Container Type: Blister Pack; Container Material: PVC/Al; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Estat d'Autorització:

Licence status A

Data d'autorització:

2014-08-22